AstraZeneca says U.S. trial data shows its Covid-19 vaccine is 79 percent effective

LONDON – AstraZeneca’s Covid-19 vaccine is safe and 79 percent effective against the disease. This emerges from the test results published by the company on Monday.

AstraZeneca will now publish its data for analysis by the scientific community in peer-reviewed literature and apply to the Food and Drugs Administration for emergency approval.

The Phase 3 study, which was conducted in the United States, Chile, and Peru with 32,000 volunteers, also shows that the vaccine is 100 percent effective against serious illness and hospitalization Company said in a press release.

More than 50 countries around the world have approved the AstraZeneca vaccine, which was developed in partnership with Oxford University, including the UK, which approved it in December and vaccinated half of its adult population.

The results showed an even higher rate of effectiveness than studies conducted at Oxford, the company said.

Download the NBC News App for breaking news and politics

“These results are great news as they show the vaccine’s remarkable efficacy in a new population and are in line with results from studies conducted by Oxford,” said Andrew Pollard, Professor of Pediatric Infections and Immunity and Senior Investigator of the Oxford University Process.

“We can expect strong effects on Covid-19 in all ages and for people from different backgrounds if we have the vaccine widely used.”

This is a groundbreaking story. Check here for updates

Leave a Comment